The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...

Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN® (naloxone HCl) ...

The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan ...

US FDA approves Henlius and Organon’s Poherdy, the first Perjeta biosimilar: Shanghai Tuesday, November 18, 2025, 16:00 Hrs [IST] Shanghai Henlius Biotech, Inc., a global health ...

In June 2024, EPKINLY monotherapy was granted accelerated approval by the FDA for the treatment of R/R FL following two or more lines of systemic therapy. With the results from the confirmatory Phase ...

Zydus won final FDA approval to market a generic version of Vumerity for adults with relapsing forms of MS and active SPMS.

THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / ...

With this approval, Thrombate III is the only antithrombin concentrate approved in both adults and pediatric patients with hereditary antithrombin deficiency.

AbbVie (ABBV) announced that EPKINLY, a T-cell engaging bispecific antibody administered subcutaneously, in combination with ...

The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...

Georgia Attorney General Chris Carr is warning families about 7-OH, a potent opioid-like substance being sold in gas stations ...